Gene therapy for HIV infection

Clinical and Experimental Immunology, Supplement

Volumn 107, Issue SUPPL. 1, 1997, Pages 41-44

  Morgan, R A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

AIDS; Antisense RNA; Retroviral vector; Transdominant Rev

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; GENE TECHNOLOGY; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL;

CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, REV; GENE THERAPY; GENES, REGULATOR; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; TRANS-ACTIVATION (GENETICS);

EID: 0031014829     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Estimates of HIV prevalence and projected AIDS cases: summary of a workshop October 31-November 1, 1989. MMWR 1990; 39: 110-19.
2. Gallo RC, Salahuddin SZ, Popovic M et al. Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224:500-5.
3. Barre-Sinoussi F, Nugeyre M, Dauguet C et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 1983; 220:868-73.
4. Popovic M, Sarngadharon MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224:497-501.
5. Curran JW, Jaffe HW, Hardy AM. Epidemiology of HIV infection and AIDS in the United States. Science 1988; 239:610-17.
6. Mann J, Chin J, Piot P, Quinn T. The international epidemiology of AIDS. Scientific American 1988; 259:82-9.
7. Morgan RA, Anderson WF. Human gene therapy. Ann Rev Biochem 1993; 62:191-217.
8. VandenDriessche T, Chuah MKL, Morgan RA. Gene therapy for acquired immune deficiency syndrome. In: DeVita VT, Hellman S, Rosenberg SA, eds. AIDS Updates. Philadelphia: J.B. Lippincott Co., 1994 vol. 7 (4):1-14.
9. Chuah ML, VandenDriessche T, Chang HK et al. Inhibition of human immunodeficiency virus Type-1 by retroviral vectors expressing anti-sense TAR. Hum Gene Therapy 1994; 5:1467-75.
10. Ragheb J, Bressler P, Daucher M et al. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV-1 replication, and their use as anti-HIV gene therapeutics. AIDS Res Hum Retroviruses 1995; 11:1343-53 .
11. Chang H, VandenDriessche T, Chuah MK et al. Inhibition of HIV-1 replication by simultaneously blocking Tat and Rev function with vectors expressing an antisense tat/rev RNA. AIDS Res Hum Retroviruses (in press).
12. + T lymphocytes by retroviral vectors expressing anti-HIV Genes. J Virol 1995; 69:4045-52.